Lorraine A. Cazenave

Author

Also Known As

L Cazenave, L. A. Cazenave, Lorraine A. Cazenave, Lorraine Cazenave

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Lorraine A. Cazenave is an author at National Cancer Institute specializing in radiation oncology, surgery, and colorectal cancer.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	43
2	Surgical Oncology	1	1	43
3	Cancer Therapeutics	1	1	43
4	Cancer Research	1	1	43
5	Colorectal Cancer	1	1	43

Lorraine A. Cazenave

Publications

351

Citations

H-Index

Page 1

	Year	Citations
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia HM Kantarjian, Miloslav Beran, Amy Ellis, Blood	1993	132
Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia HM Kantarjian, Miloslav Beran, Amy Ellis, Blood	1993	94
Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies Paula M. Fracasso, Peter Westerveldt, Carole A. Fears, Journal of Clinical Oncology	2000	82
Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer Scott Wadler, Laura Tenteromano, Lorraine A. Cazenave, Cancer Chemotherapy and Pharmacology Surgical OncologyPhase Ii TrialGastrointestinal OncologyMedicineCancer Management	1994	43

Page 1